ADC Therapeutics SA 10-Q filing
Filed 2025-11-10 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001628280-25-051095
- Form type
- 10-Q
- CIK
- 0001771910
- Primary document
- https://www.sec.gov/Archives/edgar/data/1771910/000162828025051095/adc-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ADC Therapeutics SA.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $51.2M | - | - |
| Operating Income | $-103.6M | - | - |
| Net Income | $-136.2M | - | - |
| Eps Basic | -1.14 | - | - |
| Eps Diluted | -1.14 | - | - |
| Cash And Equivalents | $234.7M | - | - |
| Total Assets | $289.8M | - | - |
| Total Liabilities | $527.9M | - | - |
| Shareholders Equity | $-238.2M | - | - |
| Operating Cash Flow | $-110.1M | - | - |
| Capital Expenditures | $264,000 | - | - |